A Case Report of Ischemic Stroke in a Patient with Metastatic Gastric Cancer Secondary to Treatment with the Vascular Endothelial Growth Factor Receptor-2 Inhibitor Ramucirumab

Publisher： Karger

E-ISSN： 1662-6575|9|2|317-320

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.9, Iss.2, 2016-06, pp. : 317-320

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autocrine Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor-2 Growth Pathway Represents a Cyclooxygenase-2-Independent Target for the Cyclooxygenase-2 Inhibitor NS-398 in Colon Cancer Cells

By  

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 204-211

Karger

Access to resources Recommend Favorite

Effect of Vascular Endothelial Growth Factor and Its Receptor Inhibitor on Proliferation and Invasion in Bladder Cancer

By  

Urologia Internationalis, Vol. 83, Iss. 1, 2009-07 ,pp. : 98-106

Karger

Access to resources Recommend Favorite

Everolimus in Metastatic Renal Cell Carcinoma after Failure of Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFr-TKI) Therapy: Results of an Interim Analysis of a Non-Interventional Study

By  

Oncology Research and Treatment, Vol. 36, Iss. 3, 2013-02 ,pp. : 95-100

Karger

Access to resources Recommend Favorite

Clinicopathologic Significance of Nuclear Factor-κB and Vascular Endothelial Growth Factor Expression in Advanced Gastric Cancer Patients

By  

Oncology Research and Treatment, Vol. 37, Iss. 4, 2014-03 ,pp. : 183-190

Karger

Access to resources Recommend Favorite

Correlation of Vascular Endothelial Growth Factor-C Expression with Tumor-Infiltrating Dendritic Cells in Gastric Cancer

By  

Oncology, Vol. 62, Iss. 2, 2002-03 ,pp. : 121-127

Karger

Access to resources Recommend Favorite